中国人群评估芦曲泊帕治疗拟择期侵袭性手术慢性肝病患者血小板减少症III期临床研究
[Translation] Phase III clinical study evaluating rutrombopag in the treatment of thrombocytopenia in patients with chronic liver disease undergoing elective invasive surgery in Chinese population
主要目的是验证在中国人群中S-888711治疗拟进行择期侵袭性手术的慢性肝病患者血小板减少症的效果优效于安慰剂对照。
[Translation] The primary objective was to verify that S-888711 was superior to placebo in the treatment of thrombocytopenia in patients with chronic liver disease who were scheduled to undergo elective invasive surgery in the Chinese population.
100 Clinical Results associated with Suzhou Yiteng Pharmaceutical Sales Co Ltd.
0 Patents (Medical) associated with Suzhou Yiteng Pharmaceutical Sales Co Ltd.
100 Deals associated with Suzhou Yiteng Pharmaceutical Sales Co Ltd.
100 Translational Medicine associated with Suzhou Yiteng Pharmaceutical Sales Co Ltd.